Founded in 2014, Varocto Inc. is an ophthalmic research and development company located in the City of Orange, California. Varocto is a spin-off of Alfred E. Mann Institute at USC. We are developing the next generation non-invasive retinal vascular screening machine utilizing OCT (Optical Coherence Tomography) and OCTA (Optical Coherence Tomographic Angiography). OCT angiography is a non-invasive new technology to image the three dimensional vasculature of the eye without requiring pupil dilation and without any injection of dye. For many eye diseases including diabetes and age-related macular degeneration, non-invasive screening for the occurrence of retinal vascular problems before vision has been damaged has the potential to improve overall eye health.